Mirum Pharmaceuticals (MIRM) Shares Outstanding (2018 - 2026)

Mirum Pharmaceuticals has reported Shares Outstanding for 9 years, with the latest figure at $60.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 23.2% year-over-year to $60.9 million; the trailing twelve-month figure through Mar 2026 stood at $60.9 million (up 23.2% YoY), and the FY2025 full-year result was $51.9 million, up 7.36% from the prior year.
• Shares Outstanding for Q1 2026 stood at $60.9 million, up from $51.9 million in the prior quarter.
• The five-year high for Shares Outstanding was $60.9 million in Q1 2026, with the low at $31.7 million in Q1 2022.
• Average Shares Outstanding over 5 years is $44.8 million, with a median of $47.1 million recorded in 2024.
• Year-over-year, Shares Outstanding increased 26.57% in 2023 and increased 2.95% in 2024.
• Tracing MIRM's Shares Outstanding over 5 years: stood at $37.0 million in 2022, then climbed by 26.43% to $46.7 million in 2023, then gained by 3.46% to $48.3 million in 2024, then increased by 7.36% to $51.9 million in 2025, then climbed by 17.4% to $60.9 million in 2026.
• The last three Shares Outstanding figures came in at $60.9 million (Q1 2026), $51.9 million (Q4 2025), and $51.3 million (Q3 2025), per Business Quant data.

Peer Comparison